Michael Charness News Today

Corporate funding is provided by mutual of america designing customized individual and Group Retirement products. Thats why were your retirement company. Additional support has been provided by and by the corporation for public broadcasting, and by contributions to your pbs station from viewers like you. Thank you. From the tisch wnet studios at Lincoln Center in new york, hari sreenivasan. Sreenivasan good evening and thanks for joining us. A Small Town Church about 30 miles east of san antonio...

The efforts, known as "Access Sprints," also opened up VA appointments for those waiting for care in the community.

Luxury homes range from a Tudor with a sunroom to a high-rise condo with floor-to-ceiling windows. Read about who bought and sold them.

Scientists from Scripps Research Translational Institute in La Jolla, California found that people who use Paxlovid are twice as likely to suffer a COVID-19 rebound as their peers.

It’s not an official medical diagnosis, but the general public sure sees it that way.

Americans have been quick to embrace the idea that the antiviral drug is to blame for COVID-19 relapses in people just days after theyve seemingly recovered.

Cases of Covid-19 rebound following treatment with the antiviral medication Paxlovid -- where infections rev back up again after people complete their five-day course of the medication -- appear to

Americans have embraced the idea that Paxlovid is to blame for COVID-19 relapses in people who've seemingly recovered. Scientists aren't so sure.

Pfizer predicted $32 billion in profits from its COVID-19 shots and another $22 billion from Paxlovid — a pill used to treat COVID-19 but can cause the virus to rebound — for a total of $54 billion. While the world was plunged into a time of...